Results 141 to 150 of about 16,123 (208)

Modelling the effects of human SUR1 R1420H variation on insulin secretory function using isogenic iPSC-derived pancreatic islets. [PDF]

Diabetologia
Nair AK, Barkho K, Cheranda KP, Traurig M, Sutherland JR, Anup D, Bogardus C, Baier LJ.   +7 more
europepmc   +1 more source

Lac-Phe induces hypophagia by inhibiting AgRP neurons in mice. [PDF]

Nat Metab
Liu H, Li VL, Liu Q, Liu Y, Su C, Wong H, Yin N, Liu H, Fang X, McDermott KM, Wong H, Yu M, Tu L, Bean JC, Li Y, Wang M, Deng Y, Shi Y, Ginnard OZ, Yang Y, Han J, Burt ME, Jossy SV, Wang C, Yang Y, Arenkiel BR, Kong D, He Y, Long JZ, Xu Y.   +29 more
europepmc   +1 more source

Identification and rescue of congenital hyperinsulinism-associated ABCC8 mutations that impair K_ATP channel trafficking. [PDF]

J Biol Chem
ElSheikh A, Kuo YY, Boodhansingh KE, Yang Z, Stanley CA, De Leon DD, Shyng SL.   +6 more
europepmc   +1 more source

Physiologically Based Pharmacokinetic Modeling to Assess Perpetrator and Victim Cytochrome P450 2C Induction Risk. [PDF]

Pharmaceutics
Slavsky M, Karve AS, Hariparsad N.
europepmc   +1 more source

An FDA-Validated, Self-Cleaning Liquid Chromatography-Mass Spectrometry System for Determining Small-Molecule Drugs and Metabolites in Organoid/Organ-on-Chip Medium. [PDF]

Anal Chem
Kogler S, Pedersen GM, Martínez-Ramírez F, Aizenshtadt A, Busek M, Krauss SJK, Wilson SR, Røberg-Larsen H.   +7 more
europepmc   +1 more source

A rare case of gliclazide-induced symptomatic bradycardia in type 2 diabetes mellitus. [PDF]

JCEM Case Rep
Kumar A, Garg S, Bharti P, Zutshi B, Ambedare S, Yadav V.   +5 more
europepmc   +1 more source

Effect of Small Molecular Additives on Growth Rates of Molecular Crystals from the Melt near Glass-Transition Temperature. [PDF]

Cryst Growth Des
Shtukenberg AG, Zhou H, Finkelstein E, Dioume A.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmacogenetics of Tolbutamide Metabolism in Humans

Diabetes, 1978
This study was designed to focus on the genetic control of tolbutamide disposition in humans and to provide insight into the potential for high accrued blood levels in individuals receiving fixed dosage regimens. Tolbutamide was administered intravenously to 42 nondiabetic subjects, eight of their relatives, and to five sets of twins.
P L Poffenbarger
exaly   +3 more sources